Study on the hepatocellular carcinoma model with metastasis

par Lin, Yu-Lin, Li, Yan
Publié dans Genes Dis (2020)

The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review

par Lin, Yu-Lin, Ma, Ru, Li, Yan
Publié dans J Cancer Res Clin Oncol (2020)

Trifluridine/tipiracil in combination with local therapy may be a favorable option for refractory metastatic colorectal cancer patients: A case report

par Lin, Yu-Lin, Liu, Kao-Lang, Lin, Been-Ren
Publié dans Medicine (Baltimore) (2020)

Overall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Sta...

par Lin, Been-Ren, Lin, Yu-Lin, Lai, Hong-Shiee, Lee, Po-Huang, Chang, King-Jen, Liang, Jin-Tung
Publié dans PLoS One (2015)

Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines

par Lin, Yu-Lin, Xu, Da-Zhao, Li, Xin-Bao, Yan, Feng-Cai, Xu, Hong-Bin, Peng, Zheng, Li, Yan
Publié dans Orphanet J Rare Dis (2021)

Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer

par Yang, Po-Chih, Lin, Been-Ren, Chen, Yi-Chang, Lin, Yu-Lin, Lai, Hong-Shiee, Huang, Kai-Wen, Liang, Jin-Tung
Publié dans Medicine (Baltimore) (2016)

Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity

par Wang, Chia-Chun, Liang, Jin-Tung, Tsai, Chiao-Ling, Chen, Yu-Hsuan, Lin, Yu-Lin, Shun, Chia-Tung, Cheng, Jason Chia-Hsien
Publié dans World J Surg Oncol (2014)

CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma

par Liao, Wei-Chih, Wang, Hsiu-Po, Huang, Hsin-Yi, Wu, Ming-Shiang, Chiang, Hung, Tien, Yu-Wen, Lin, Yu-Lin, Lin, Jaw-Town
Publié 2012

MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib

par Huang, Ming-Hung, Lee, Jih-Hsiang, Chang, Ya-Ju, Tsai, Hsin-Hui, Lin, Yu-Lin, Lin, Anya Maan-Yuh, Yang, James Chih-Hsin
Publié dans Mol Oncol (2012)

Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwi...

par Chen, Kuo-Hsing, Shao, Yu-Yun, Chen, Ho-Min, Lin, Yu-Lin, Lin, Zhong-Zhe, Lai, Mei-Shu, Cheng, Ann-Lii, Yeh, Kun-Huei
Publié dans BMC Cancer (2016)

Establishment of patient‐derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal inje...

par Lin, Yu‐Lin, Zhang, Jue, Yan, Feng‐Cai, Jiang, Xi, Ma, Ru, Yang, Zhi‐Ran, Xu, Hong‐Bin, Peng, Zheng, Chen, Qian, Li, Yan
Publié dans Cancer Med (2019)

KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells

par Lin, Yu-Lin, Liau, Jau-Yu, Yu, Shan-Chi, Ou, Da-Liang, Lin, Liang-In, Tseng, Li-Hui, Chang, Yih-Leong, Yeh, Kun-Huei, Cheng, Ann-Lii
Publié 2012

Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal mesothelioma

par Yang, Zhi-Ran, Chen, Zhi-Gao, Ji, Zhong-He, Lin, Yu-Lin, Zhang, Jue, Ma, Ru, Li, Zhao, Jiang, Xi, Chen, Qian, Du, Xue-Mei, Li, Yan
Publié dans Exp Anim (2021)

Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer

par Lin, Yu-Lin, Liau, Jau-Yu, Yu, Shan-Chi, Tseng, Li-Hui, Lin, Liang-In, Liang, Jin-Tung, Lin, Ben-Ren, Hung, Ji-Shiang, Chang, Yih-Leong, Yeh, Kun-Huei, Cheng, Ann-Lii
Publié 2013

Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients

par Lin, Yu-Lin, Liang, Yi-Hsin, Tsai, Jia-Huei, Liau, Jau-Yu, Liang, Jin-Tung, Lin, Been-Ren, Hung, Ji-Shiang, Lin, Liang-In, Tseng, Li-Hui, Chang, Yih-Leong, Yeh, Kun-Huei, Cheng, Ann-Lii
Publié 2014